Abstract
Allergen bronchoprovocation tests have been used for more than two decades in the investigation of respiratory allergic diseases such as asthma and rhinitis. These bronchial challenges are now well standardized and can offer key information on the therapeutic potential of new agents and on their anti-inflammatory effects on the airways. Both standard and low-dose allergen provocations are safe when performed by experienced investigators and do not lead to persistent worsening of asthma or change in airway function. The evaluation of new therapeutic agents by these methods can also provide important information on the mechanisms of development and persistence of airway diseases.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Allergens* / immunology
-
Animals
-
Anti-Inflammatory Agents / therapeutic use*
-
Asthma / blood
-
Asthma / diagnosis*
-
Asthma / drug therapy*
-
Asthma / immunology
-
Bronchial Provocation Tests / methods*
-
Bronchoconstriction / drug effects
-
Bronchoconstriction / immunology
-
Humans
-
Inflammation / blood
-
Inflammation / drug therapy*
-
Inflammation / immunology
-
Models, Immunological
-
Predictive Value of Tests
-
Respiratory Function Tests / methods
-
Respiratory Function Tests / standards
-
Rhinitis / blood
-
Rhinitis / diagnosis
-
Rhinitis / drug therapy
-
Rhinitis / immunology
-
Skin Tests / methods
-
Skin Tests / standards
Substances
-
Allergens
-
Anti-Inflammatory Agents